Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome

Recruiting Observational Study
Prader-Willi Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 – 16
Sex
Any
Study type
Observational
Participants needed
75 (estimated)
Sponsor
University Hospital, Toulouse · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Prader-Willi Syndrome (PWS) is a rare neurodevelopmental disorder stemming from genetic damage in the 15q11-q13 region, leading to hypothalamic dysfunction. Individuals with PWS often exhibit social interaction challenges, intellectual deficits, significant eating disorders, mood disturbances, and sensory-related autistic features. Although PWS is recognized by DSM-5 as a genetic cause of Autism S…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Child with genetically confirmed PWS and identification of genetic subtype; * Child aged between 3 and 16 years; * Hospitalisation or multidisciplinary consultation planned for the child's routine follow-up at one of the investigating centres; * No parental/legal guardian obje…
Contacts

Nadege ALGANS

0561777204

algans.n@chu-toulouse.fr

CONTACT